PATENT CLAIM ANALYSIS

Application Number: 16042670
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "263230"]

Abstract:
The present specification discloses compositions comprising a plurality of therapeutic compound having antitussive activity and methods and uses for treating a coughing condition with such compositions.

Claim (Index 16):
The method according to  claim 15 , wherein the therapeutically-effective amount of the oral pharmaceutical composition administered to the individual comprises between 60 mg/day and 120 mg/day of Theobromine, 37.5 mg/day and 75 mg/day of Diphenhydramine, and 15 mg/day and 30 mg/day of Phenylephrine.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15063465', '14287017', '14287015', '15061656', '14287014']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.829295452923806
- 35 USC 102 Novelty (BERT): 0.5648601362293508
- Combined Prediction Score: 0.8028519212543604
- Mean Citation Score: 424.682136
- Max Citation Score: 456.2595
- Similarity Product: 373.0752475610376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test